Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Sportradar Group AG posted a 19% increase in revenue for Q2 2026 to €378 million, driven by growth in Betting Technology & Solutions and Sports Content services. Adjusted EBITDA also rose 19% to €76 million with margin expansion. The company expanded its market presence via multi-year partnerships with prediction market platforms Kalshi and Polymar…
BCB Bancorp, Inc. (NASDAQ: BCBP) reported a net loss of $14.8 million for the second quarter of 2026, a significant deterioration from net income in both the previous quarter and prior year. The loss was driven by a $19 million provision for credit losses, a $5.3 million goodwill impairment, and a $2.6 million loss on loan sales. The company announ…
Eva Live Inc. announces the creation of Eva Defense Inc.'s advisory board with the appointments of General Robert Brooks Brown and Ross Mandel. This step initiates Eva Live's expansion into the defense sector, leveraging its AI technology to develop integrated military-grade products such as autonomous drones, command consoles, and resilient commun…
Lantronix Inc., an Edge AI and Industrial IoT solutions provider, announced that its CEO and CFO will participate in upcoming investor conferences hosted by Canaccord Genuity and Needham. These engagements include a fireside chat and multiple one-on-one meetings aimed at discussing the company's growth and strategic initiatives in high-growth techn…
Adlai Nortye Ltd., a clinical-stage biotech company, announced the submission of Clinical Trial Notification to Australia's regulatory body and approval from the Human Research Ethics Committee to begin a global Phase I trial of AN4035, a first-in-class antibody drug conjugate (ADC) targeting CEACAM5 with a pan-RAS(ON) inhibitor payload. The trial …
Can-Fite BioPharma has submitted a Phase 2 clinical trial protocol for Piclidenoson to treat Lowe syndrome, a rare genetic disease with no approved treatments. This open-label, single-center study will evaluate safety and efficacy in 5 adult patients, focusing on kidney function improvement. The drug is already in Phase 3 trials for psoriasis and h…
Opus Genetics has completed patient enrollment in its registrational Phase 3 trial of OPGx-LCA5, an investigational gene therapy for LCA5-associated inherited retinal disease. The trial design aligns with FDA Rare Disease Evidence Principles, aiming for a Biologics License Application submission based on six-month efficacy data expected by the end …
Douglas Dynamics, Inc. (NYSE: PLOW) announced record second quarter 2026 financial results with net sales increasing 10% to $214.6 million and adjusted EBITDA rising 5% to a record $44.6 million. The company reported adjusted diluted EPS growth of 7% to $1.22 and returned $10 million in cash to shareholders. Strong snowfall led to robust preseason …
Deutsche Bank raised its S&P 500 earnings-per-share forecasts for 2026 and 2027 after a wide-ranging and unusually strong slate of second-quarter results. The bank highlighted a record-high share of firms beating estimates, robust aggregate beats driven by both revenue and margin strength, and upward revisions to forward earnings at a stage when an…
Nearly 1,300 pilots at Allegiant Travel have ratified a two-year collective bargaining agreement that raises hourly pay substantially, unlocks roughly $300 million in accrued retention bonuses, and improves retirement benefits and workplace rules. The vote follows several years of fraught negotiations that included airport pickets in November 2025.
A recent Nexus/BTG Pactual poll finds President Luiz Inacio Lula da Silva and Senator Flavio Bolsonaro virtually tied as Brazil moves toward the October presidential election. In a hypothetical second-round runoff Lula holds 46% to Bolsonaro's 45%, while first-round figures show Lula at 41% and Bolsonaro at 37%. The survey of 2,002 respondents was …
Eton Pharmaceuticals will report its second quarter 2026 financial results on August 13, 2026, followed by a management conference call and webcast. The company focuses on developing and commercializing treatments for rare diseases and currently markets eleven rare disease products, with several additional candidates in late-stage development.
ExxonMobil (XOM) is attractive today as a practical capital-return trade: steady dividend, large buyback capacity and improving technicals give a favorable risk/reward for a 180-trading-day position. Market-cap discipline (market cap ~$686B) and a PE of ~20 leave room for upside if the company sustains payout growth or accelerates repurchases. This…
Amazon's ramp in AI infrastructure and product integration is shifting from R&D to strategic advantage. The company is building proprietary chips, embedding models across retail, ads and logistics, and using scale to compress competitors' margins. This trade idea outlines a long entry with clear risk controls and a horizon tied to execution milesto…
Brookfield Asset Management has finalized its acquisition of Oaktree, enhancing its credit investing capabilities and expanding its global reach. The merger strengthens Brookfield's credit business across multiple credit strategies and solidifies the U.S. as its largest market, accounting for over 60% of employees and nearly half of revenue.
Japan and the United States carried out coordinated yen-buying intervention last week, a rare joint action intended to blunt rapid falls in the currency. The intervention produced a sizeable short-covering reaction and pushed the yen higher to about 155.20 per dollar, yet analysts warn that without faster Bank of Japan rate hikes the gains are like…
Bank Indonesia's acting governor said a recent policy package is meant to deter commercial banks from treating BI's rupiah securities as investment vehicles and to encourage greater lending. The comments came at a Financial System Stability Board press event following the central bank governor's surprise resignation and measures to alter reserve re…
Supernus Pharmaceuticals delivered a 32% increase in total revenues to $219.1 million for Q2 2026, driven by strong sales growth of its CNS-focused products including Qelbree, GOCOVRI, ZURZUVAE, and ONAPGO. Collaboration revenue with Biogen on ZURZUVAE further boosted results. The company raised its full-year 2026 revenue guidance and announced an …
Integer Holdings Corporation reported a slight decline in organic sales and operating income in Q2 2026 compared to Q2 2025 but delivered stable adjusted net income and a small increase in adjusted EPS. The company also disclosed a definitive agreement for an all-cash acquisition by KKR valuing Integer at $5.7 billion, with stockholders to receive …
Indivior Pharmaceuticals delivered robust second quarter 2026 financial results, highlighted by a 14% year-over-year increase in total net revenue to $343 million and 21% growth in flagship SUBLOCADE net revenue. Record GAAP and non-GAAP net incomes and a 111% rise in adjusted EBITDA from the prior year underscore operational strength. The company …
Global Partners LP (GLP) offers an attractive income entry today: a 6%+ yield, a reasonable P/E near 14, and operational leverage to rising fuel margins. We set a clear trade plan with entry at $49.50, a $56.00 target and a $45.00 stop, and argue for a long-term hold to capture distributions and commodity tailwinds while watching cyclical risk and …
Supernus Pharmaceuticals and Indivior Pharmaceuticals have agreed to merge in a tax-free all-stock transaction to create a large CNS-focused biopharmaceutical company expected to generate $2.2 billion in combined annual revenue and $125 million in annual cost synergies. The combined entity will operate under the name Supernus, Inc. with Jack Khatta…
Integer Holdings Corporation, a leading global medical device contract manufacturer, has agreed to be acquired by private equity firm KKR in a $5.7 billion all-cash transaction. Shareholders will receive $127 per share, representing a 51.8% premium over the pre-review price. The deal follows a strategic review and aims to provide Integer with capit…
Diginex Limited announced it has obtained $70 million in private funding commitments to finance its proposed acquisition of Resulticks and has extended the acquisition long-stop date to August 12, 2026. The transaction remains subject to customary conditions and approvals, with no guarantee of completion.
Parsons Corporation has been selected as the lead designer for the Interstate 526 Long Point Road Interchange Improvements project in South Carolina. As part of the Ames Construction design-build team, Parsons will provide engineering and design services to enhance safety, reduce congestion, and improve mobility in Charleston's busy transportation …
